Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers.
Rani KhatibKay MarshallJon SilcockClaire ForrestAlistair S HallPublished in: Open heart (2019)
Using appropriate self-report tools, patients share actual and potential modifiable barriers to adherence that can be addressed in clinical practice. Non-adherence behaviour was selective. Most non-adherence was driven by forgetfulness, concern about the harm caused by SPM and practical barriers.
Keyphrases
- coronary artery disease
- end stage renal disease
- clinical practice
- ejection fraction
- glycemic control
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- prognostic factors
- heart failure
- percutaneous coronary intervention
- metabolic syndrome
- cardiovascular events
- adipose tissue
- insulin resistance
- coronary artery bypass grafting
- aortic stenosis